BOT 5.26% 36.0¢ botanix pharmaceuticals ltd

Ann: BTX 1503 End of Phase 2 Milestone with FDA, page-112

  1. 4,177 Posts.
    lightbulb Created with Sketch. 5443
    Am I missing something here.

    The only good part of the timeline is the 1801 phase 2b which is coming this year.

    There appears to be no news on the rosacea phase 1B which was approved to commence this year, and now they also need a follow on phase 2 which has not started, before completing the plan to start the phase 3..... I can see 1503 blowing out until 2023 - particularly with one liners in there like " when covid restrictions stop " When is that going to happen ?

    Not good enough - just run the entire trial in WA with restrictions before all the cash is burnt through !!!!!!!

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.